Martin Cowie

Rob Dillard

DocwireNews

The European Society of Cardiology (ESC) Task Force recently completed a Focused Update of their 2021 guidelines for the diagnosis and treatment of acute and chronic heart failure (HF). Notably, SGLT2 inhibitors received a Class I recommendation for HF with a mildly reduced and preserved ejection fraction.In this interview, DocWire News spoke with Martin Cowie, clinical vice president, cardiovascular and heart failure, biopharmaceuticals R&amp;D at AstraZeneca, who reviewed the ESC&rsquo;s updated guidelines and discussed the SGLT2 inhibitor Farxiga, one of the HF therapies with a Class 1A recommendation.Mr. Cowie also detailed 2 trials that played a central role in these guideline updates, the DAPA-HF and DELIVER trials.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Martin Cowie, of AstraZeneca, Discusses the ESC 2023 Heart Failure Guidelines Update

Heart Failure

Martin Cowie, of AstraZeneca, reviews the ESC's recently updated guidelines for acute and chronic heart failure and discusses Forxiga, an SGLT2 inhibitor.

Martin Cowie, AstraZeneca, Discusses the ESC 2023 Heart Failure Guidelines Update

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe